Tag: Generative artificial intelligence

Browse our exclusive articles!

Indian Tech Giants Developing AI Competitor to Sam Altman’s ChatGPT

Discover how Indian tech giants Zoho, Tech Mahindra, and Tata Consultancy Services are developing generative AI platforms to rival ChatGPT by Sam Altman. Will they succeed?

Generative AI has Multi-Billion Dollar Potential, Study Finds

Discover how generative artificial intelligence (GenAI) could revolutionize industries like customer service, software development, marketing, and research & development. According to a McKinsey study, GenAI could increase annual productivity by 2.4 to 4.1 trillion euros, with industries like retail and consumer goods benefiting the most. However, the integration of this technology could lead to the automation of some complex and highly-paid jobs. Overall, GenAI is expected to contribute significantly to economic and technological growth in the coming years.

Ex-Facebook and Google experts team up to develop ChatGPT’s rival costing $260.

Discover Mistral AI, a new player in the generative AI market that just raised $113 million in seed funding. Led by former Facebook and Google experts, their goal is to create open-source, socially responsible technology.

AI Risks and Benefits Will Rise Together, Warns ChatGPT CEO

OpenAI plans to establish an office in Japan due to their high regard for human and machine collaboration. CEO Sam Altman discusses the need for global regulation of AI to balance benefits with potential risks.

US Researchers Warn Doctor ChatGPT Needs Human Backup

Don't rely solely on AI assistants like ChatGPT for medical advice! A recent study by UC San Diego suggests only 22% of answers provided specific resources. Chatbots should offer the option to connect with human experts. Seek medical advice from licensed professionals.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img